AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

Shares of UnitedHealth Group (NYSE:UNH) soared on Friday with news that several prominent investors had purchased shares of the health insurance company. A well-known member of Congress is also buying ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.

Although it sounds like an oxymoron, high-growth prospect dividend aristocrat stocks exist, although their industries may ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie, in collaboration with REGENXBIO Inc., is ...

AbbVie is investing $195 million to build a new north Chicago manufacturing plant to expand its active pharmaceutical ingredient production in the U.S. The investment is part of the biopharmaceutical ...

This activity is supported by independent medical education grants from 4D Molecular Therapeutics; AbbVie Inc.; Adverum Biotechnologies, Inc.; Alkeus Pharmaceuticals, Inc.; Astellas; EyePoint ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.